8 results in Exploration of Targeted Anti-tumor Therapy
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Review
Emerging molecular therapies in the treatment of bladder cancer
Scott D. Bell ... Yujiang Fang
Published: August 29, 2024 Explor Target Antitumor Ther. 2024;5:1135–1154
This article belongs to the special issue Emerging Molecular Targets and Therapies of Genitourinary Tumors
1954 39 0
Open Access Review
Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies
Neha Thakur ... Sunny Dholpuria
Published: August 29, 2024 Explor Target Antitumor Ther. 2024;5:1110–1134
This article belongs to the special issue Mechanisms of Targeted Therapy Resistance and Reversal Strategies
4069 77 3
Open Access Original Article
Evaluation of HER2 immunohistochemistry expression in non-standard solid tumors from a Single-Institution Prospective Cohort
Saurav Verma ... Daniel Breadner
Published: August 22, 2024 Explor Target Antitumor Ther. 2024;5:1100–1109
1941 30 2
Open Access Review
Anticancer peptides as novel immunomodulatory therapeutic candidates for cancer treatment
Apurva Sood ... Anuradha Sharma
Published: August 21, 2024 Explor Target Antitumor Ther. 2024;5:1074–1099
3913 92 6
Open Access Review
Hematopoietic and leukemic stem cells homeostasis: the role of bone marrow niche
Shaimaa Khattab ... Pier Paolo Piccaluga
Published: August 15, 2024 Explor Target Antitumor Ther. 2024;5:1027–1055
This article belongs to the special issue Mechanisms of Targeted Therapy Resistance and Reversal Strategies
2846 31 1
Open Access Review
Prospects for breast cancer immunotherapy using microRNAs and transposable elements as objects
Rustam Nailevich Mustafin
Published: August 06, 2024 Explor Target Antitumor Ther. 2024;5:1011–1026
1898 29 1
Open Access Review
Combination of the PARPi and ARSi in advanced castration resistant prostate cancer: a review of the recent phase III trials
Martina Panebianco ... Mario Rosario D’Andrea
Published: August 02, 2024 Explor Target Antitumor Ther. 2024;5:997–1010
1588 37 1